PTC Therapeutics Inc (PTCT) financials · rev $1.73B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
PTC Therapeutics Inc (PTCT) rev $1.73B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.73B | $806.8M |
| Operating Income | $866.9M | -$302.6M |
| Net Income | $682.6M | -$363.3M |
| EPS (Diluted) | $7.78 | -$4.73 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $2.90B | $1.71B |
| Current Assets | $2.27B | $1.37B |
| Cash & Equivalents | $984.6M | $779.7M |
| Inventory | $79.6M | $23.2M |
| PP&E | $55.4M | $61.0M |
| Total Liabilities | $3.10B | $2.80B |
| Current Liabilities | $968.4M | $581.0M |
| Short-term Debt | $286.6M | N/A |
| Long-term Debt | N/A | $285.4M |
| Total Debt | $286.6M† | $285.4M† |
| Shareholders' Equity | -$205.3M | -$1.10B |
| Retained Earnings | -$2.96B | -$3.65B |
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $711.2M | -$107.7M |
| CapEx | $8.86M | $6.50M |
| Investing Cash Flow | -$862.0M | $44.2M |
| Financing Cash Flow | $331.1M | $255.9M |
| Net Change in Cash | $203.0M | $185.0M |
| Free Cash Flow | $702.3M | -$114.2M |
FAQ
What is PTCT P/E and revenue?
PTC Therapeutics Inc (PTCT) rev $1.73B.
What is PTCT revenue?
PTC Therapeutics Inc last cached revenue is $1.73B (FY2025).
Is PTCT profitable?
PTC Therapeutics Inc last cached net income is $682.6M (FY2025).
What are PTCT total assets?
PTC Therapeutics Inc last cached total assets are $2.90B (FY2025).
What is PTCT free cash flow?
PTC Therapeutics Inc last cached free cash flow is $702.3M (FY2025).
Not investment advice. Cached statements, not a live tape.